A nurse is preparing to administer cimetidine 300 mg IV over 15 min to a client. Available is cimetidine 300 mg/100 mL of 0.9% sodium chloride. The nurse should set the IV pump to deliver how many mL/hr?
(Round the answer to the nearest whole number. Use a leading zero if it applies. Done use a trailing zero.)

A. A client received 0900 medications at 0930:
This situation involves a medication administration error where the medications were administered later than the scheduled time. An incident report should be completed to document the error, investigate the circumstances, and implement measures to prevent recurrence.
B. A client who has asthma was administered tiotropium via inhalation:
Tiotropium is an appropriate medication for asthma. As long as it was administered according to the prescribed guidelines, there is no need for an incident report.
C. A client received a blood transfusion with dextrose 5% in water:
This situation involves a significant medication error, as dextrose 5% in water is not the appropriate solution for a blood transfusion. An incident report should be completed to document the error, investigate the circumstances, and implement measures to prevent recurrence.
D. A client received an infusion of lipids through a central line:
If the infusion of lipids through a central line was ordered and administered appropriately, there is no need for an incident report. Lipid infusions are commonly administered through central lines when indicated.

A. INR (International Normalized Ratio): INR is a measure of blood clotting and is not directly affected by filgrastim, which stimulates the production of white blood cells. Monitoring INR is more relevant when assessing anticoagulant therapy.
B. Potassium level: Filgrastim does not directly influence potassium levels. Monitoring potassium is important for certain medications and conditions, but it is not the primary parameter to evaluate the effectiveness of filgrastim.
C. WBC count: Filgrastim (granulocyte colony-stimulating factor) is used to stimulate the production of white blood cells, specifically neutrophils. Monitoring the white blood cell count is crucial in evaluating the effectiveness of filgrastim treatment. An increase in the WBC count, particularly the neutrophil count, indicates a positive response to the medication.
D. BUN (Blood Urea Nitrogen): BUN is a measure of kidney function and is not directly influenced by filgrastim. While monitoring kidney function is important in general patient care, it is not the primary parameter to assess the effectiveness of filgrastim.